Today: 9 April 2026
Nvidia stock price rises today as China signals H200 AI chip orders could restart (NVDA)
23 January 2026
2 mins read

Nvidia stock price rises today as China signals H200 AI chip orders could restart (NVDA)

New York, January 23, 2026, 09:36 AM ET — Regular session underway.

  • Nvidia shares climbed in early trading following reports that Chinese regulators instructed leading tech companies to get ready to order its H200 AI chips
  • The shift unfolds amid investor concerns over export-policy risks and the Federal Reserve’s decision looming next week
  • Nvidia will release its quarterly earnings on Feb. 25

NVIDIA Corp shares climbed on Friday following a report that Chinese authorities instructed Alibaba, Tencent, and ByteDance to start preparing orders for Nvidia’s H200 AI chips. Investors saw this as a sign of progress toward reopening the crucial Chinese market. The stock gained 0.8% to $184.84, after earlier jumping nearly 3%. Bloomberg

This report is significant because Nvidia’s sales in China have been unpredictable, caught in the crossfire of U.S. export restrictions and Beijing’s scrutiny over advanced chip destinations. Traders want something solid—an order, a confirmed shipment date—anything that shifts “maybe” into actual revenue.

The tape was unsettled as chip stocks showed a mixed picture, with Intel slipping on a disappointing outlook. Investors brace for a busy week loaded with earnings reports and a Fed meeting. “Guidance now is more critical than ever,” noted Peter Cardillo, chief market economist at Spartan Capital Securities. Reuters

Earlier this month, the Trump administration formally approved China-bound H200 sales, but with strings attached: third-party testing before export and caps tied to U.S. sales, per the new rules. Nvidia hailed the regulation as “a thoughtful balance that is great for America.” Seaport Research’s Jay Goldberg, however, dismissed it as “a Band-Aid,” cautioning that enforcing these measures could get tricky. Reuters

Beijing’s position remains unclear. Nvidia CEO Jensen Huang is set to visit China in late January, coinciding with Lunar New Year festivities, Bloomberg reported earlier this week. The trip aims to help Nvidia regain ground in the Chinese market; the company declined to comment. Reuters

Still, the downside remains a real risk. That initial approval might hit a wall, Washington could crank up the pressure, and new restrictions could tighten around Chinese buyers—limiting who accesses the chips and how they use them.

The next clear trigger is in Washington, not Santa Clara. The Fed convenes Jan. 27-28, with its policy call set for 2 p.m. ET on Jan. 28, then a press briefing at 2:30 p.m. Federal Reserve

Next week’s earnings season will put the broader “AI trade” under the microscope. Around 20% of the S&P 500 is set to report, and investors are eager to see AI spending translate into actual profits, not just capital expenditures. “At the end of the day, earnings are the driver,” said Chris Galipeau, senior market strategist at Franklin Templeton. Reuters

Nvidia’s next key date is Feb. 25, when it’s set to release its fourth-quarter fiscal 2026 results, per the company’s investor calendar. NVIDIA Investor Relations

Traders will be closely tracking if “prepare orders” shift into actual purchase orders and if clearer timing on shipments to China comes through. The Fed’s decision on Jan. 28 looms as the immediate challenge, with Nvidia’s update on Feb. 25 set to be the next major event for NVDA.

Stock Market Today

  • Sumitomo Pharma's New Shares and Secondary Offering Could Shift Investment Outlook
    April 9, 2026, 4:32 AM EDT. Sumitomo Pharma (TSE:4506) plans a new share issuance combined with a secondary offering, potentially altering ownership and per-share economics. The initiative comes after a recent guidance upgrade, projecting increased revenue and net profit by fiscal 2026 thanks to stronger sales and currency effects. Despite this, the offering does not change the core risks: high debt levels and reliance on one-off gains. Analysts remain divided, with some forecasting more optimistic earnings growth while others caution on sustainability. The company projects modest revenue growth to 2029, with earnings expected to decline from current levels. This share move introduces new tension between near-term earnings support and balance sheet pressure as the company advances regenerative therapies and North American projects. Investors should weigh revised forecasts and changing capital structure carefully.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 4:41 AM EDT Sumitomo Pharma's New Shares and Secondary Offering Could Shift Investment Outlook April 9, 2026, 4:32 AM EDT. Sumitomo Pharma (TSE:4506) plans a new share issuance combined with a secondary offering, potentially altering ownership and per-share economics. The initiative comes after a recent guidance upgrade, projecting increased revenue and net profit by fiscal 2026 thanks to stronger sales and currency effects. Despite this, the offering does not change the core risks: high debt levels and reliance on one-off gains. Analysts remain divided, with some forecasting more
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Tesla stock jumps on Austin robotaxi step as Musk talks Optimus timeline ahead of earnings
Previous Story

Tesla stock jumps on Austin robotaxi step as Musk talks Optimus timeline ahead of earnings

Microsoft stock rises after Microsoft 365 outage clears as MSFT heads into earnings week
Next Story

Microsoft stock rises after Microsoft 365 outage clears as MSFT heads into earnings week

Go toTop